NCT03326505View on ClinicalTrials.gov

Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

January 25, 2020

Study Completion Date

February 20, 2020

Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL

Umbilical cord derived Mesenchymal Stem Cells

Allogenic umbilical cord derived stem cells which are to be injected intrathecally as a treatment option for consenting MS patients

OTHER

Supervised physical therapy

A combined physical therapy program of Balance, strengthening and endurance exercises

Trial Locations (2)

11942

Cell Therapy Center, University of Jordan, Amman

Cell Therapy Center, Amman

All Listed Sponsors
lead

University of Jordan

OTHER

NCT03326505 - Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment | Biotech Hunter | Biotech Hunter